Alain Vicari

Immunology and Microbiology · Life Sciences

38h-index10.1kcitations79works3.52yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(37), T-cell and B-cell Immunology(29), Immune Cell Function and Interaction(20), Immune Response and Inflammation(16), Chemokine receptors and signaling(16)

Publications79 total

789 CALY-002, AN ANTI-IL-15 ANTIBODY, PREVENTS GLUTEN CHALLENGEINDUCED MUCOSAL DAMAGE AND INFLAMMATION: RESULTS FROM A PHASE 1A/B STUDY
Gastroenterology·2024· 5 cited
962 CALY-002, AN ANTI-IL-15 ANTIBODY, RESULTS IN HISTOLOGICAL AND CLINICAL IMPROVEMENT IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS IN A PHASE 1A/B STUDY
Gastroenterology·2024· 2 cited
43761 Experimentally induced atopic dermatitis lesions in xenotransplanted skin are ameliorated by interleukin 15 (IL-15) inhibition
Journal of the American Academy of Dermatology·2023
10th antibody industrial symposium: new developments in antibody and adoptive cell therapies
mAbs·2023Open Access
1021 INTERIM RESULTS FROM A FIRST-IN-HUMAN STUDY OF THE ANTI-IL-15 ANTIBODY CALY-002 FOR TREATING CELIAC DISEASE AND EOSINOPHILIC ESOPHAGITIS
Gastroenterology·2023
Supplementary Figure 2 from Redirecting <i>In vivo</i> Elicited Tumor Infiltrating Macrophages and Dendritic Cells towards Tumor Rejection
2023Open Access
Supplementary Figure 3 from Redirecting <i>In vivo</i> Elicited Tumor Infiltrating Macrophages and Dendritic Cells towards Tumor Rejection
2023Open Access
Supplementary Figure 1 from Redirecting <i>In vivo</i> Elicited Tumor Infiltrating Macrophages and Dendritic Cells towards Tumor Rejection
2023Open Access
Supplementary Figure 1 from Redirecting <i>In vivo</i> Elicited Tumor Infiltrating Macrophages and Dendritic Cells towards Tumor Rejection
2023Open Access
Supplementary Figure Legends from Redirecting <i>In vivo</i> Elicited Tumor Infiltrating Macrophages and Dendritic Cells towards Tumor Rejection
2023Open Access
Data from Redirecting <i>In vivo</i> Elicited Tumor Infiltrating Macrophages and Dendritic Cells towards Tumor Rejection
2023Open Access
Supplementary Figure 3 from Redirecting <i>In vivo</i> Elicited Tumor Infiltrating Macrophages and Dendritic Cells towards Tumor Rejection
2023Open Access
Supplementary Figure 2 from Redirecting <i>In vivo</i> Elicited Tumor Infiltrating Macrophages and Dendritic Cells towards Tumor Rejection
2023Open Access
Data from Redirecting <i>In vivo</i> Elicited Tumor Infiltrating Macrophages and Dendritic Cells towards Tumor Rejection
2023Open Access
Supplementary Figure Legends from Redirecting <i>In vivo</i> Elicited Tumor Infiltrating Macrophages and Dendritic Cells towards Tumor Rejection
2023Open Access
L’Œsophagite à Éosinophiles : de l’ombre à la lumière
HEGEL - HEpato-GastroEntérologie Libérale·2022Open Access
Congrès de l’AGA 2017 : le point sur la transplantation fécale
HEGEL - HEpato-GastroEntérologie Libérale·2017Open Access
Discovery and characterization of a novel humanized anti-IL-15 antibody and its relevance for the treatment of refractory celiac disease and eosinophilic esophagitis
mAbs·2017· 44 citedOpen Access
Blocking Interleukin-15 as a New Strategy for the Treatment of Eosinophilic Esophagitis
Gastroenterology·2017
La mystérieuse œsophagite à éosinophiles garde encore quelques secrets
HEGEL - HEpato-GastroEntérologie Libérale·2017Open Access
page 1 of 4Next →

Frequent Co-authors

Albert Zlotnik(16), Christophe Caux(13), Giorgio Trinchieri(9), Smina Aït‐Yahia(8), Béatrice Vanbervliet(6), Anne O’Garra(6), Arthur Μ. Krieg(6), Marie‐Caroline Dieu‐Nosjean(5), Bernhard Homey(5), Neal G. Copeland(5), Catherine Massacrier(5), Karine Chemin(5), André Herbelin(5), Serge Lebecque(4), Joseph A. Hedrick(4), Nancy A. Jenkins(4), Debra J. Gilbert(4), Maria Leite‐de‐Moraes(4), M Papiernik(4), Francine Brière(3)